Posts

Global ⁠Asthma – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Global ⁠ Asthma Market Outlook Thelansis’s “Global ⁠ Asthma Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035 ″  covers disease overview, epidemiology, kidney biopsy cases, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Asthma treatment modalities options for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America). Global ⁠ Asthma Overview Asthma is a chronic inflammatory airway disease characterised by variable, reversible airflow obstruction, bronchial hyperresponsiveness, and airway remodelling, driven predominantly by Th2-mediated eosinophilic inflammation — with type 2 cytokines IL-4, IL-5, and IL-13 central to its pathobiology — alongside non-eosinophilic neutrophilic and mixed phenotypes recognising asthma’s...
Post a Comment
Read more

Global ⁠Brain Metastasis (BM) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Global ⁠ Brain Metastasis (BM) Market Outlook Thelansis’s “Global ⁠ Brain Metastasis (BM) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report (Top 32 Markets) – 2025 To 2035 ″  covers disease overview, epidemiology, kidney biopsy cases, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Brain Metastasis treatment modalities options for the 32 markets (North America, Europe, Middle East, Asia Pacific, Africa, South / Latin America). Global ⁠ Brain Metastasis (BM) Overview Brain metastasis is the most prevalent intracranial malignancy in adults, occurring when neoplastic cells from a primary tumor—overwhelmingly originating from the lung, breast, melanoma, or kidney—disseminate hematogenously, breach the blood-brain barrier, and colonize the central nervous system parenchyma. Clinically, patient...
Post a Comment
Read more

Herpetic Keratitis (HK) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Herpetic Keratitis (HK) Market Outlook Thelansis’s “Herpetic Keratitis (HK) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Herpetic Keratitis (HK) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Herpetic Keratitis (HK) Overview Herpetic keratitis (HK) is a leading infectious cause of corneal blindness worldwide, caused predominantly by herpes simplex virus type 1 (HSV-1) — and less commonly HSV-2 — following primary ocular infection and subsequent latency establishment within the trigeminal ganglion, with recurrent reactivation driving progressive corneal damage. The pathophysiology involves both direct viral cytopathic i...
Post a Comment
Read more

Familial Adenomatous Polyposis (FAP) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Familial Adenomatous Polyposis (FAP) Market Outlook Thelansis’s “Familial Adenomatous Polyposis (FAP) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Familial Adenomatous Polyposis (FAP) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Familial Adenomatous Polyposis (FAP) Overview Familial adenomatous polyposis (FAP) is a hereditary colorectal cancer syndrome caused by autosomal dominant germline mutations in the APC tumour suppressor gene, leading to constitutive Wnt/β-catenin pathway activation and progressive development of hundreds to thousands of colorectal adenomatous polyps — with virtually inevitable malignant trans...
Post a Comment
Read more

Microvillus Inclusion Disease (MVID) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Microvillus Inclusion Disease (MVID) Market Outlook Thelansis’s “Microvillus Inclusion Disease (MVID) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Microvillus Inclusion Disease (MVID) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Microvillus Inclusion Disease (MVID) Overview Microvillus inclusion disease (MVID) is an ultra-rare, life-threatening congenital enteropathy caused by autosomal recessive loss-of-function mutations in MYO5B — encoding myosin Vb, critical for apical membrane trafficking and brush border formation — and less commonly STX3 and STXBP2, disrupting enterocyte polarity and microvillus assembly. The ...
Post a Comment
Read more

Metastatic Cutaneous Melanoma – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Metastatic Cutaneous Melanoma Market Outlook Thelansis’s “Metastatic Cutaneous Melanoma Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Metastatic Cutaneous Melanoma treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Metastatic Cutaneous Melanoma Overview Metastatic cutaneous melanoma is an aggressive malignancy arising from melanocytes, transformed by remarkable therapeutic advances. BRAF V600 mutations — present in approximately 50% of cases — alongside NRAS, CDKN2A, and PTEN alterations drive MAPK pathway activation and immune evasion. Comprehensive staging incorporating PET-CT, brain MRI, and molecular profiling — includi...
Post a Comment
Read more

Relapsed or Refractory Waldenstrom Macroglobulinemia (r/r WM) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Relapsed or Refractory Waldenstrom Macroglobulinemia (r/r WM) Market Outlook Thelansis’s “Relapsed or Refractory Waldenstrom Macroglobulinemia (r/r WM) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Relapsed or Refractory Waldenstrom Macroglobulinemia (r/r WM) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Relapsed or Refractory Waldenstrom Macroglobulinemia (r/r WM) Overview Relapsed or refractory Waldenström macroglobulinaemia (r/r WM) is a rare, indolent B-cell lymphoplasmacytic lymphoma characterised by clonal accumulation of IgM-secreting lymphoplasmacytic cells within the bone marrow, and defined by near-universal ...
Post a Comment
Read more